US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.591
- -0.179-23.28%
Close Nov 14 16:00 ET
- 0.620
- +0.029+4.87%
Post 20:02 ET
151.28MMarket Cap-3540P/E (TTM)
0.810High0.583Low14.52MVolume0.810Open0.771Pre Close8.90MTurnover8.51%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High1.89P/B100.91MFloat Cap0.42052wk Low--Dividend TTM170.69MShs Float21.570Historical High--Div YieldTTM29.42%Amplitude0.420Historical Low0.612Avg Price1Lot Size
Adaptimmune Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Nov 14, 2024
The average Adaptimmune Therapeutics stock price target is 3.33 with a max estimate of 3.50 and a min estimate of 3.15
Review Adaptimmune Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Nov 14, 2024
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
